ROE tells a less flattering adjusted story than the headline: the 17.9% print in 2025Q4 alongside a 26.6% net margin, versus a normalized 5-8% range, appears consistent with a non-operating item rather than improved earning power, so underlying ROE is closer to the 4.4% recorded in 2026Q3. The gap between ROIC of roughly 5% and ROE of roughly 4-8% indicates modest positive leverage contribution, but the primary constraint appears to be the low 0.26-0.31 asset turnover, which anchors returns regardless of the 300 basis point gross margin expansion. Investors should monitor whether utilization gains translate into ROIC above 7-8%, as anything less may indicate capital is being retained without compounding.

The DSO improvement is the standout, though analysts should note that DSO and DIO are reported unavailable in 2025Q4, the quarter with the anomalous 28.5% FCF margin, so the working capital swing that produced that cash surge cannot be fully decomposed from the disclosed ratios. DPO has barely moved at 24-30 days, suggesting the DSO gains reflect receivables management or contract structure rather than any stretching of supplier terms, which limits the risk of a reversal as suppliers tighten. Given that prior cash flow findings show working capital swings exceeded any single quarter's operating earnings, this CCC improvement appears to be a genuine efficiency gain but one whose durability depends on maintaining the favorable project mix that drove collections.

The deleveraging trajectory is the clearest structural improvement in the financial profile, reducing D/EBITDA from 10.3x to 6.7x, though the latter figure still sits above investment-grade comfort levels for a business whose revenue remains tied to volatile offshore capital spending. Coverage at 8.89x suggests debt service is comfortable today, but the wide quarterly swings in interest coverage, including an outlier 82.21x in 2025Q3, indicate EBITDA volatility rather than debt movement is the dominant variable. The one caveat for credit analysis is the large negative AOCI implied by the equity build, which may mean the book equity cushion overstates the economic capital available to absorb losses.

The gap between trailing P/E of 11.53x and forward P/E of 19.63x is notable and, read alongside the consensus-driven EV/EBITDA compression from 9.35x to 8.82x, suggests the market is pricing in an earnings decline rather than continued margin expansion, which sits awkwardly against the recent guidance raise. P/B of 3.78x is the most demanding multiple relative to the fundamentals, given ROIC near 5% and ROE under 8%; at these return levels, book-value-based valuation offers limited support if the offshore cycle turns. The bull case for re-rating likely depends on the market assigning a standalone valuation to the ADTech and IMDS segments rather than applying a blended offshore services multiple.